OVERVIEW OF TUBERCULOSIS PREVENTIVE TREATMENT AMONG CHILDREN IN SURABAYA
Downloads
Background: A high prevalence of tuberculosis (TB) infection rates is followed by high rates of TB infection in children. The TB Preventive Treatment (TPT) for children with Isoniazid (INH) is one of the primary activities to improve TB cases by finding them early to prevent the transmission of TB to children. Purpose: This study aimed to describe the implementation of TPT with prophylactic INH among children in Surabaya. Methods: This research was a descriptive observational study with a case series design using secondary data on the provision of TPT in children, child TB cases in Surabaya City in 2016–2018, and a network of partnerships with hospitals/clinics/doctors’ private practices for the prevention and control of TB in the city of Surabaya in 2016–2018 as the population. The data were collected by in-depth interviews with the holders of the TB prevention and control program of Surabaya. The data were analyzed by comparing and describing the targets and achievements of the INH administration in children. Results: The implementation of INH for children in Surabaya is not optimal and has not reached the targets. The networking of health facilities with providers for the provision of TPT with INH for children is still low in Surabaya City. Conclusions: Delivery of INH for children in Surabaya has been implemented and has increased, however, it is not optimal because it has not reached the targeted districts/municipalities that determined.
Datiko, D. G., Yassin, M. A., Theobald, S. J., & Cuevas, L. E. (2017). A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia. International Journal of Tuberculosis and Lung Disease, 21(9), 1002–1007. https://doi.org/10.5588/ijtld.16.0471
Dewi, S., Damsar, & Azwar. (2019). Analisis kendala implementasi program penanggulangan tuberkulosis di Kecamatan Meral Kabupaten Karimun. Jurnal Ilmu Sosial dan Ilmu Politik, 9(1), 28–48.
Diallo, T., Adjobimey, M., Ruslami, R., Trajman, A., Sow, O., Obeng Baah, J., … Menzies, D. (2018). Safety and side effects of rifampin versus isoniazid in children. New England Journal of Medicine, 379(5), 454–463. https://doi.org/10.1056/NEJMoa1714284
Dlamini, N. C., Ji, D. Der, & Chien, L. Y. (2019). Factors associated with isoniazid resistant tuberculosis among human immunodeficiency virus positive patients in Swaziland: a case-control study. BMC Infectious Diseases, 19(1), 1–8. https://doi.org/10.1186/s12879-019-4384-6
Dodd, P. J., Yuen, C. M., Sismanidis, C., Seddon, J. A., & Jenkins, H. E. (2017). The global burden of tuberculosis mortality in children: a mathematical modelling study. The Lancet Global Health, 5(9), e898–e906. https://doi.org/10.1016/S2214-109X(17)30289-9
Egere, U., Sillah, A., Togun, T., Kandeh, S., Cole, F., Jallow, A., … Kampmann, B. (2016). Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in the Gambia. Public Health Action, 6(4), 226–231. https://doi.org/10.5588/pha.16.0073
Gegia, M., Winters, N., Benedetti, A., van Soolingen, D., & Menzies, D. (2017). Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. The Lancet Infectious Diseases, 17(2), 223–234. https://doi.org/https://doi.org/10.1016/S1473-3099(16)30407-8
Gupta, A., Montepiedra, G., Aaron, L., Theron, G., McCarthy, K., Bradford, S., … Weinberg, A. (2019). Isoniazid preventive therapy in HIV-infected pregnant and postpartum women. New England Journal of Medicine, 381(14), 1333–1346. https://doi.org/10.1056/NEJMoa1813060
Jenkins, H. E. (2016). Global burden of childhood tuberculosis. Pneumonia, 8(1), 1–7. https://doi.org/10.1186/s41479-016-0018-6
Karo, B., Kohlenberg, A., Hollo, V., Duarte, R., Fiebig, L., Jackson, S., … van der Werf, M. J. (2019). Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014. Eurosurveillance, 24(12), 1–13. https://doi.org/10.2807/1560-7917.ES.2019.24.12.1800392
Lee, M.-R., Huang, H.-L., Lin, S.-W., Cheng, M.-H., Lin, Y.-T., Chang, S.-Y., … Chong, I.-W. (2019). Isoniazid concentration and NAT2 genotype predict risk of systemic drug reactions during 3HP for LTBI. Journal of Clinical Medicine, 8(6), 812. https://doi.org/10.3390/jcm8060812
Ministry of Health RI. (2016). Minister of health RI’s regulation number 67 of 2016 concerning tuberculosis control. Jakarta: Ministry of Health RI.
Moonan, P. K., Nair, S. A., Agarwal, R., Chadha, V. K., Dewan, P. K., Gupta, U. D., … Khaparde, S. D. (2018). Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India. BMJ Global Health, 3(5), e001135. https://doi.org/10.1136/bmjgh-2018-001135
Nyathi, S., Dlodlo, R. A., Satyanarayana, S., Takarinda, K. C., Tweya, H., Hove, S., … Harries, A. D. (2019). Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe. PLoS ONE, 14(10), 1–12. https://doi.org/10.1371/journal.pone.0223076
Pal, R., Hameed, S., Sabareesh, V., Kumar, P., Singh, S., & Fatima, Z. (2018). Investigations into isoniazid treated mycobacterium tuberculosis by electrospray mass spectrometry reveals new insights into its lipid composition. Journal of Pathogens, 2018, 1–14. https://doi.org/10.1155/2018/1454316
Prieske, O., Krüger, T., Aehle, M., Bauer, E., & Granacher, U. (2018). Effects of resisted sprint training and traditional power training on sprint, jump, and balance performance in healthy young adults: a randomized controlled trial. Frontiers in Physiology, 9, 1–10. https://doi.org/10.3389/fphys.2018.00156
Romanowski, K., Campbell, J. R., Oxlade, O., Fregonese, F., Menzies, D., & Johnston, J. C. (2019). The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study. PLoS ONE, 14(1), 1–15. https://doi.org/10.1371/journal.pone.0211355
Surabaya City Health Office. (2019). Health profile of Surabaya City at 2018. Surabaya City Health Office. Surabaya.
Susetyowati, H. M., Ningtyias, F. W., & Prasetyo, A. (2018). The role of cadres in improving the succes of preventive treatment programs with isoniazid (PP INH) in Jember. Multidisciplinary Journal, 1(1), 17–20.
Swaminathan, S., & Ramachandran, G. (2015). Challenges in childhood tuberculosis. Clinical Pharmacology & Therapeutics, 98(3), 240–244. https://doi.org/10.1002/cpt.175
Swindells, S., Ramchandani, R., Gupta, A., Benson, C. A., Leon-Cruz, J., Mwelase, N., … Chaisson, R. E. (2019). One month of rifapentine plus isoniazid to prevent HIV-related tuberculosis. New England Journal of Medicine, 380(11), 1001–1011. https://doi.org/10.1056/NEJMoa1806808
Zunza, M., Gray, D. M., Young, T., Cotton, M., & Zar, H. J. (2017). Isoniazid for preventing tuberculosis in HIV-infected children (review). Cochrane Database of Systematic Reviews, (8), 1–32. https://doi.org/10.1002/14651858.CD006418.pub3
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
